MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 71 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59 | -28.9% | 12,225 | +0.6% | 0.00% | – |
Q2 2023 | $83 | -12.6% | 12,150 | -0.3% | 0.00% | – |
Q1 2023 | $95 | -38.7% | 12,183 | -40.1% | 0.00% | – |
Q4 2022 | $155 | -99.9% | 20,348 | -0.0% | 0.00% | – |
Q3 2022 | $166,000 | -15.3% | 20,357 | +0.3% | 0.00% | – |
Q2 2022 | $196,000 | -15.9% | 20,298 | +22.1% | 0.00% | – |
Q1 2022 | $233,000 | +65.2% | 16,621 | +141.0% | 0.00% | – |
Q4 2021 | $141,000 | +54.9% | 6,896 | +68.2% | 0.00% | – |
Q3 2021 | $91,000 | – | 4,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $11,469,458 | 5.52% |
NEA Management Company, LLC | 7,692,298 | $59,923,001 | 4.14% |
Cormorant Asset Management, LP | 2,893,717 | $22,542 | 1.48% |
Alphabet Inc. | 1,464,015 | $11,404,677 | 0.63% |
Avoro Capital Advisors LLC | 4,325,000 | $33,691,750 | 0.50% |
Casdin Capital, LLC | 510,882 | $3,979,771 | 0.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,156 | $242,705 | 0.10% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $219,616 | 0.04% |
UBS OCONNOR LLC | 95,528 | $744,163 | 0.02% |
ExodusPoint Capital Management, LP | 261,593 | $2,038 | 0.02% |